Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (141-150 of 676) with videos related to

Pageof 68
Sort By:
Expert Opinion on Pharmacotherapy|March 27, 2014
Use of mTOR inhibitors in the treatment of malignanciesNisha A Mohindra, Francis J Giles, Leonidas C Platanias
Leukemia & Lymphoma|December 24, 2014
Predicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failureJason B Kaplan, Leonidas C Platanias, Francis J Giles
Journal of Hematology & Oncology|September 14, 2022
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8<sup>+</sup> T cell cytolytic killing of melanoma cellsGary Shaw, Ludimila Cavalcante, Francis J Giles, et al.
The Western Journal of Medicine|May 1, 1982
Vaginal ectopic ureter: a continuing diagnostic challengeD J Giles, G W Nixon, A W Middleton
Expert Review of Hematology|November 19, 2010
Clinical activity of laromustine (Onrigin™) in hematologic malignanciesYesid Alvarado, Ronan Swords, Kevin R Kelly, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A ReviewF Ravandi-Kashani, C Sriswasdi, A Lynott, et al.
Biochemistry|February 11, 2017
X-ray Absorption Spectroscopy Reveals an Organometallic Ni-C Bond in the CO-Treated Form of Acetyl-CoA SynthaseMehmet Can, Logan J Giles, Stephen W Ragsdale, et al.
Journal of the American Academy of Dermatology|July 29, 2004
Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomasApostolia-Maria Tsimberidou, Francis J Giles, Madeleine Duvic, et al.
Cellular Immunology|October 15, 1992
Effect of immunosuppressive therapy on cytolytic activity of immunodeficient mice: implications for xenogeneic transplantationL A Cavacini, J Giles-Komar, M Kennel, et al.
Expert Opinion on Pharmacotherapy|June 24, 2004
An update on the management of chronic lymphocytic leukaemiaKaren W L Yee, Susan M O'Brien, Francis J Giles
Pageof 68

Showing results (141-150 of 676) with videos related to

Sort By:
Pageof 68
Expert Opinion on Pharmacotherapy|March 27, 2014
Use of mTOR inhibitors in the treatment of malignanciesNisha A Mohindra, Francis J Giles, Leonidas C Platanias
Leukemia & Lymphoma|December 24, 2014
Predicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failureJason B Kaplan, Leonidas C Platanias, Francis J Giles
Journal of Hematology & Oncology|September 14, 2022
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8<sup>+</sup> T cell cytolytic killing of melanoma cellsGary Shaw, Ludimila Cavalcante, Francis J Giles, et al.
The Western Journal of Medicine|May 1, 1982
Vaginal ectopic ureter: a continuing diagnostic challengeD J Giles, G W Nixon, A W Middleton
Expert Review of Hematology|November 19, 2010
Clinical activity of laromustine (Onrigin™) in hematologic malignanciesYesid Alvarado, Ronan Swords, Kevin R Kelly, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A ReviewF Ravandi-Kashani, C Sriswasdi, A Lynott, et al.
Biochemistry|February 11, 2017
X-ray Absorption Spectroscopy Reveals an Organometallic Ni-C Bond in the CO-Treated Form of Acetyl-CoA SynthaseMehmet Can, Logan J Giles, Stephen W Ragsdale, et al.
Journal of the American Academy of Dermatology|July 29, 2004
Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomasApostolia-Maria Tsimberidou, Francis J Giles, Madeleine Duvic, et al.
Cellular Immunology|October 15, 1992
Effect of immunosuppressive therapy on cytolytic activity of immunodeficient mice: implications for xenogeneic transplantationL A Cavacini, J Giles-Komar, M Kennel, et al.
Expert Opinion on Pharmacotherapy|June 24, 2004
An update on the management of chronic lymphocytic leukaemiaKaren W L Yee, Susan M O'Brien, Francis J Giles
Pageof 68